Kosnopfel, C., Sinnberg, T., Sauer, B., Niessner, H., Schmitt, A., Makino, E., . . . Schittek, B. (2017). Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase. Oncotarget.
Chicago-stil citatKosnopfel, Corinna, et al. "Human Melanoma Cells Resistant to MAPK Inhibitors Can Be Effectively Targeted By Inhibition of the P90 Ribosomal S6 Kinase." Oncotarget 2017.
MLA-referensKosnopfel, Corinna, et al. "Human Melanoma Cells Resistant to MAPK Inhibitors Can Be Effectively Targeted By Inhibition of the P90 Ribosomal S6 Kinase." Oncotarget 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.